S&P 500, Dow futures turn positive on COVID-19 vaccine hopes


July 20 (Reuters) - Futures tracking the S&P 500 and Dow indexes pared early declines to trade marginally higher, as hopes of a coronavirus vaccine offset concerns about the economic damage from a surge in domestic COVID-19 infections.

German biotech firm BioNTech BNTX.O and U.S. drugmaker Pfizer PFE.N reported additional data from their experimental coronavirus vaccine that showed the vaccine was safe and induced an immune response in patients.

At 9:01 a.m. ET, Dow e-minis 1YMcv1 were up 15 points, or 0.06%, and S&P 500 e-minis EScv1 were up 1.25 points, or 0.04%. Nasdaq 100 e-minis NQcv1, which were up before the report, hit session highs.

(Reporting by Sagarika Jaisinghani in Bengaluru; Editing by Shounak Dasgupta)

((; within U.S. +1 646 223 8780; outside U.S. +91 80 6182 2256;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.